| NDC Code | 51267-890-00 |
|---|
| Package Description | 70 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-00) |
|---|
| Product NDC | 51267-890 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Contrave |
|---|
| Proprietary Name Suffix | Extended-release |
|---|
| Non-Proprietary Name | Naltrexone Hydrochloride And Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140910 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA200063 |
|---|
| Manufacturer | Orexigen Therapeutics, Inc. |
|---|
| Substance Name | NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE |
|---|
| Strength | 8; 90 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
|---|